Dallah Healthcare Holding Co. reported a net profit of SAR 155 million for the first half of 2017, jumping 38 percent year-on-year (YoY), driven by lower G&A expenses and decreased Zakat. In addition, there was some impairment in intangible assets in the same quarter of last year which were not repeated this year.
Item | 6m 2016 | 6m 2017 | Change |
---|---|---|---|
Revenues | 573.38 | 590.95 | 3.1 % |
Gross Income | 262.31 | 274.08 | 4.5 % |
Operating Income | 121.24 | 156.67 | 29.2 % |
Net Income | 112.20 | 155.03 | 38.2 % |
Average Shares | 90.00 | 90.00 | - |
EPS (Riyals) | 1.25 | 1.72 | 38.2 % |
The company’s net profit for the second quarter increased 29.3 percent YoY to SAR 70 million on increase in number of medical procedures, higher operating efficiency and cost-saving policy.
On a quarterly basis, Q2 net profit fell 17.6 percent on seasonality factors, as the holy month of Ramadan and Eid Al Fitr fell in Q2.
Item | Q2 2016 | Q2 2017 | Change |
---|---|---|---|
Revenues | 288.35 | 288.20 | 0.0 % |
Gross Income | 129.78 | 130.48 | 0.5 % |
Operating Income | 59.34 | 70.86 | 19.4 % |
Net Income | 54.14 | 69.99 | 29.3 % |
Average Shares | 90.00 | 90.00 | - |
EPS (Riyals) | 0.60 | 0.78 | 29.3 % |
Item | Q1 2017 | Q2 2017 | Change |
---|---|---|---|
Revenues | 302.75 | 288.20 | (4.8 %) |
Gross Income | 143.60 | 130.48 | (9.1 %) |
Operating Income | 85.82 | 70.86 | (17.4 %) |
Net Income | 85.05 | 69.99 | (17.7 %) |
Average Shares | 90.00 | 90.00 | - |
EPS (Riyals) | 0.94 | 0.78 | (17.7 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2008 | - | - | - | - | - | - |
Q2 2008 | - | - | - | - | - | - |
Q3 2008 | - | - | - | - | - | - |
Q4 2008 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
Q1 2009 | - | - | - | - | - | - |
Q2 2009 | - | - | - | - | - | - |
Q3 2009 | - | - | - | - | - | - |
Q4 2009 | - | - | - | - | - | - |
2009 | 513.86 | - | 155.79 | - | 73.83 | - |
Q1 2010 | - | - | - | - | - | - |
Q2 2010 | - | - | - | - | - | - |
Q3 2010 | 104.78 | - | 36.90 | - | 18.24 | - |
Q4 2010 | 120.09 | - | 39.97 | - | 17.35 | - |
2010 | 472.52 | (8.0 %) | 169.83 | 9.0 % | 88.85 | 20.4 % |
Q1 2011 | 129.97 | - | 49.69 | - | 30.24 | - |
Q2 2011 | 139.34 | - | 50.86 | - | 26.45 | - |
Q3 2011 | 115.44 | 10.2 % | 37.37 | 1.3 % | 16.67 | (8.6 %) |
Q4 2011 | 142.59 | 18.7 % | 51.97 | 30.0 % | 27.94 | 61.0 % |
2011 | 527.34 | 11.6 % | 189.89 | 11.8 % | 101.30 | 14.0 % |
Q1 2012 | 154.04 | 18.5 % | 72.82 | 46.5 % | 38.00 | 25.7 % |
Q2 2012 | 161.32 | 15.8 % | 73.73 | 45.0 % | 38.16 | 44.2 % |
Q3 2012 | 142.26 | 23.2 % | 59.00 | 57.9 % | 22.41 | 34.4 % |
Q4 2012 | 179.43 | 25.8 % | 81.51 | 56.9 % | 32.18 | 15.2 % |
2012 | 636.86 | 20.8 % | 286.87 | 51.1 % | 130.75 | 29.1 % |
Q1 2013 | 183.73 | 19.3 % | 84.40 | 15.9 % | 38.39 | 1.0 % |
Q2 2013 | 187.79 | 16.4 % | 80.68 | 9.4 % | 30.19 | (20.9 %) |
Q3 2013 | 167.08 | 17.4 % | 66.67 | 13.0 % | 21.95 | (2.0 %) |
Q4 2013 | 211.05 | 17.6 % | 95.71 | 17.4 % | 48.06 | 49.3 % |
2013 | 749.65 | 17.7 % | 327.45 | 14.1 % | 137.53 | 5.2 % |
Q1 2014 | 207.57 | 13.0 % | 87.60 | 3.8 % | 39.73 | 3.5 % |
Q2 2014 | 219.45 | 16.9 % | 93.78 | 16.2 % | 33.46 | 10.8 % |
Q3 2014 | 192.79 | 15.4 % | 75.36 | 13.0 % | 21.67 | (1.3 %) |
Q4 2014 | 240.08 | 13.8 % | 103.54 | 8.2 % | 50.24 | 4.5 % |
2014 | 858.75 | 14.6 % | 358.57 | 9.5 % | 145.09 | 5.5 % |
Q1 2015 | 240.40 | 15.8 % | 102.13 | 16.6 % | 39.67 | (0.1 %) |
Q2 2015 | 245.23 | 11.7 % | 100.89 | 7.6 % | 35.71 | 6.7 % |
Q3 2015 | 223.93 | 16.2 % | 87.92 | 16.7 % | 26.37 | 21.7 % |
Q4 2015 | 276.50 | 15.2 % | 116.81 | 12.8 % | 57.01 | 13.5 % |
2015 | 985.44 | 14.8 % | 407.14 | 13.5 % | 160.78 | 10.8 % |
Q1 2016 | 285.03 | 18.6 % | 132.53 | 29.8 % | 61.90 | 56.1 % |
Q2 2016 | 288.35 | 17.6 % | 129.78 | 28.6 % | 59.34 | 66.2 % |
Q3 2016 | 273.17 | 22.0 % | 122.38 | 39.2 % | 51.80 | 96.4 % |
Q4 2016 | 316.24 | 14.4 % | 151.01 | 29.3 % | 57.96 | 1.7 % |
2016 | 1,162.79 | 18.0 % | 535.70 | 31.6 % | 231.00 | 43.7 % |
Q1 2017 | 302.75 | 6.2 % | 143.60 | 8.4 % | 85.82 | 38.6 % |
Q2 2017 | 288.20 | 0.0 % | 130.48 | 0.5 % | 70.86 | 19.4 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2007 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
2009 | 513.86 | - | 155.79 | - | 73.83 | - |
2010 | 472.52 | (8.0 %) | 169.83 | 9.0 % | 88.85 | 20.4 % |
2011 | 527.34 | 11.6 % | 189.89 | 11.8 % | 101.30 | 14.0 % |
2012 | 636.86 | 20.8 % | 286.87 | 51.1 % | 130.75 | 29.1 % |
2013 | 749.65 | 17.7 % | 327.45 | 14.1 % | 137.53 | 5.2 % |
2014 | 858.75 | 14.6 % | 358.57 | 9.5 % | 145.09 | 5.5 % |
2015 | 985.44 | 14.8 % | 407.14 | 13.5 % | 160.78 | 10.8 % |
2016 | 1,162.79 | 18.0 % | 535.70 | 31.6 % | 231.00 | 43.7 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2008 | - | - | - | - | - | - |
Q2 2008 | - | - | - | - | - | - |
Q3 2008 | - | - | - | - | - | - |
Q4 2008 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
Q1 2009 | - | - | - | - | - | - |
Q2 2009 | - | - | - | - | - | - |
Q3 2009 | - | - | - | - | - | - |
Q4 2009 | - | - | - | - | - | - |
2009 | 66.04 | - | 0.73 | (3.00) | 69.04 | 0.77 |
Q1 2010 | - | - | - | - | - | - |
Q2 2010 | - | - | - | - | - | - |
Q3 2010 | 17.82 | - | 0.20 | - | 17.82 | 0.20 |
Q4 2010 | 24.33 | - | 0.27 | - | 24.33 | 0.27 |
2010 | 94.47 | 43.0 % | 1.05 | - | 94.47 | 1.05 |
Q1 2011 | 35.25 | - | 0.39 | - | 35.25 | 0.39 |
Q2 2011 | 27.14 | - | 0.30 | - | 27.14 | 0.30 |
Q3 2011 | 15.49 | (13.1 %) | 0.17 | - | 15.49 | 0.17 |
Q4 2011 | 35.53 | 46.0 % | 0.39 | (3.38) | 38.91 | 0.43 |
2011 | 113.40 | 20.0 % | 1.26 | (3.38) | 116.79 | 1.30 |
Q1 2012 | 37.96 | 7.7 % | 0.42 | - | 37.96 | 0.42 |
Q2 2012 | 37.09 | 36.7 % | 0.41 | - | 37.09 | 0.41 |
Q3 2012 | 23.94 | 54.5 % | 0.27 | - | 23.94 | 0.27 |
Q4 2012 | 34.37 | (3.3 %) | 0.38 | - | 34.37 | 0.38 |
2012 | 133.36 | 17.6 % | 1.48 | - | 133.36 | 1.48 |
Q1 2013 | 39.04 | 2.8 % | 0.43 | - | 39.04 | 0.43 |
Q2 2013 | 23.64 | (36.3 %) | 0.26 | - | 23.64 | 0.26 |
Q3 2013 | 21.84 | (8.7 %) | 0.24 | - | 21.84 | 0.24 |
Q4 2013 | 52.11 | 51.6 % | 0.58 | - | 52.11 | 0.58 |
2013 | 136.63 | 2.5 % | 1.52 | - | 136.63 | 1.52 |
Q1 2014 | 40.50 | 3.7 % | 0.45 | - | 40.50 | 0.45 |
Q2 2014 | 34.33 | 45.2 % | 0.38 | - | 34.33 | 0.38 |
Q3 2014 | 21.94 | 0.5 % | 0.24 | - | 21.94 | 0.24 |
Q4 2014 | 50.35 | (3.4 %) | 0.56 | - | 50.35 | 0.56 |
2014 | 147.12 | 7.7 % | 1.63 | - | 147.12 | 1.63 |
Q1 2015 | 47.82 | 18.1 % | 0.53 | 13.75 | 34.07 | 0.38 |
Q2 2015 | 35.86 | 4.4 % | 0.40 | - | 35.86 | 0.40 |
Q3 2015 | 26.78 | 22.1 % | 0.30 | - | 26.78 | 0.30 |
Q4 2015 | 54.60 | 8.4 % | 0.61 | - | 54.60 | 0.61 |
2015 | 165.06 | 12.2 % | 1.83 | 13.75 | 151.31 | 1.68 |
Q1 2016 | 58.07 | 21.4 % | 0.65 | (2.02) | 60.09 | 0.67 |
Q2 2016 | 54.14 | 51.0 % | 0.60 | (3.07) | 57.21 | 0.64 |
Q3 2016 | 60.80 | 127.0 % | 0.68 | 9.42 | 51.39 | 0.57 |
Q4 2016 | 51.71 | (5.3 %) | 0.57 | (6.00) | 57.71 | 0.64 |
2016 | 224.71 | 36.1 % | 2.50 | (1.68) | 226.39 | 2.52 |
Q1 2017 | 85.05 | 46.5 % | 0.94 | - | 85.05 | 0.94 |
Q2 2017 | 69.99 | 29.3 % | 0.78 | - | 69.99 | 0.78 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2007 | - | - | - | - | - | - |
2008 | - | - | - | - | - | - |
2009 | 66.04 | - | 0.73 | (3.00) | 69.04 | 0.77 |
2010 | 94.47 | 43.0 % | 1.05 | - | 94.47 | 1.05 |
2011 | 113.40 | 20.0 % | 1.26 | (3.38) | 116.79 | 1.30 |
2012 | 133.36 | 17.6 % | 1.48 | - | 133.36 | 1.48 |
2013 | 136.63 | 2.5 % | 1.52 | - | 136.63 | 1.52 |
2014 | 147.12 | 7.7 % | 1.63 | - | 147.12 | 1.63 |
2015 | 165.06 | 12.2 % | 1.83 | 13.75 | 151.31 | 1.68 |
2016 | 224.71 | 36.1 % | 2.50 | (1.68) | 226.39 | 2.52 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
2009 | 30.32 % | 18.58 % | 13.44 % |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
2010 | 35.94 % | 22.73 % | 19.99 % |
Q1 2011 | - | - | - |
Q2 2011 | 35.90 % | 22.84 % | 21.15 % |
Q3 2011 | 35.24 % | 22.42 % | 20.24 % |
Q4 2011 | 36.01 % | 24.05 % | 22.15 % |
2011 | 36.01 % | 24.05 % | 22.15 % |
Q1 2012 | 38.63 % | 24.79 % | 21.67 % |
Q2 2012 | 41.14 % | 25.88 % | 22.58 % |
Q3 2012 | 42.90 % | 25.84 % | 22.97 % |
Q4 2012 | 45.06 % | 25.05 % | 20.93 % |
2012 | 45.04 % | 25.06 % | 20.94 % |
Q1 2013 | 44.79 % | 24.18 % | 20.16 % |
Q2 2013 | 44.08 % | 22.36 % | 17.45 % |
Q3 2013 | 43.63 % | 21.80 % | 16.56 % |
Q4 2013 | 43.68 % | 23.30 % | 18.23 % |
2013 | 43.68 % | 23.16 % | 18.23 % |
Q1 2014 | 42.75 % | 23.14 % | 17.85 % |
Q2 2014 | 42.69 % | 22.94 % | 18.48 % |
Q3 2014 | 42.42 % | 22.43 % | 17.92 % |
Q4 2014 | 41.90 % | 22.11 % | 17.11 % |
2014 | 41.76 % | 22.14 % | 17.13 % |
Q1 2015 | 41.98 % | 21.38 % | 15.76 % |
Q2 2015 | 41.58 % | 21.72 % | 15.48 % |
Q3 2015 | 41.54 % | 21.77 % | 15.49 % |
Q4 2015 | 41.35 % | 21.81 % | 15.34 % |
2015 | 41.32 % | 22.03 % | 15.35 % |
Q1 2016 | 42.51 % | 23.29 % | 17.20 % |
Q2 2016 | 43.49 % | 24.24 % | 18.50 % |
Q3 2016 | 44.66 % | 25.57 % | 19.88 % |
Q4 2016 | 46.07 % | 24.94 % | 19.47 % |
2016 | 46.07 % | 24.94 % | 19.47 % |
Q1 2017 | 46.32 % | 26.38 % | 21.29 % |
Q2 2017 | 46.38 % | 27.68 % | 22.38 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2007 | - | - | - |
2008 | - | - | - |
2009 | 30.32 % | 18.58 % | 13.44 % |
2010 | 35.94 % | 22.73 % | 19.99 % |
2011 | 36.01 % | 24.05 % | 22.15 % |
2012 | 45.04 % | 25.06 % | 20.94 % |
2013 | 43.68 % | 23.16 % | 18.23 % |
2014 | 41.76 % | 22.14 % | 17.13 % |
2015 | 41.32 % | 22.03 % | 15.35 % |
2016 | 46.07 % | 24.94 % | 19.47 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | 35.22 % | 21.56 % | 17.00 % |
Q4 2010 | 33.28 % | 18.14 % | 20.26 % |
Q1 2011 | 38.23 % | 26.96 % | 27.12 % |
Q2 2011 | 36.50 % | 24.01 % | 19.47 % |
Q3 2011 | 32.37 % | 19.85 % | 13.42 % |
Q4 2011 | 36.44 % | 24.82 % | 27.29 % |
Q1 2012 | 47.27 % | 29.16 % | 24.64 % |
Q2 2012 | 45.71 % | 28.00 % | 22.99 % |
Q3 2012 | 41.48 % | 20.83 % | 16.83 % |
Q4 2012 | 45.43 % | 22.23 % | 19.16 % |
Q1 2013 | 45.94 % | 25.32 % | 21.25 % |
Q2 2013 | 42.96 % | 20.75 % | 12.59 % |
Q3 2013 | 39.90 % | 18.63 % | 13.07 % |
Q4 2013 | 45.35 % | 27.52 % | 24.69 % |
Q1 2014 | 42.20 % | 24.47 % | 19.51 % |
Q2 2014 | 42.73 % | 20.38 % | 15.64 % |
Q3 2014 | 39.09 % | 16.97 % | 11.38 % |
Q4 2014 | 43.13 % | 25.78 % | 20.97 % |
Q1 2015 | 42.48 % | 21.43 % | 14.17 % |
Q2 2015 | 41.14 % | 21.75 % | 14.62 % |
Q3 2015 | 39.26 % | 17.88 % | 11.96 % |
Q4 2015 | 42.25 % | 25.38 % | 19.75 % |
Q1 2016 | 46.50 % | 26.86 % | 21.08 % |
Q2 2016 | 45.01 % | 25.49 % | 19.84 % |
Q3 2016 | 44.80 % | 24.50 % | 18.81 % |
Q4 2016 | 47.75 % | 23.08 % | 18.25 % |
Q1 2017 | 47.43 % | 32.36 % | 28.09 % |
Q2 2017 | 45.27 % | 30.84 % | 24.28 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2008 | - | - | - | - |
Q2 2008 | - | - | - | - |
Q3 2008 | - | - | - | - |
Q4 2008 | - | - | - | - |
Q1 2009 | - | - | - | - |
Q2 2009 | - | - | - | - |
Q3 2009 | - | - | - | - |
Q4 2009 | - | - | - | - |
Q1 2010 | - | - | - | - |
Q2 2010 | - | - | - | - |
Q3 2010 | 90.00 | - | - | 3.67 |
Q4 2010 | 90.00 | - | - | 3.94 |
Q1 2011 | 90.00 | - | - | 4.29 |
Q2 2011 | 90.00 | 1.16 | 1.16 | 4.63 |
Q3 2011 | 90.00 | 1.14 | 1.14 | 4.80 |
Q4 2011 | 90.00 | 1.26 | 1.30 | 5.21 |
Q1 2012 | 90.00 | 1.29 | 1.33 | 5.66 |
Q2 2012 | 90.00 | 1.40 | 1.44 | 6.04 |
Q3 2012 | 90.00 | 1.49 | 1.53 | 6.31 |
Q4 2012 | 90.00 | 1.48 | 1.48 | 12.40 |
Q1 2013 | 90.00 | 1.49 | 1.49 | 12.83 |
Q2 2013 | 90.00 | 1.34 | 1.34 | 12.37 |
Q3 2013 | 90.00 | 1.32 | 1.32 | 12.64 |
Q4 2013 | 90.00 | 1.52 | 1.52 | 13.22 |
Q1 2014 | 90.00 | 1.53 | 1.53 | 13.75 |
Q2 2014 | 90.00 | 1.65 | 1.65 | 13.36 |
Q3 2014 | 90.00 | 1.65 | 1.65 | 13.65 |
Q4 2014 | 90.00 | 1.63 | 1.63 | 14.15 |
Q1 2015 | 90.00 | 1.72 | 1.56 | 14.74 |
Q2 2015 | 90.00 | 1.73 | 1.58 | 14.63 |
Q3 2015 | 90.00 | 1.79 | 1.63 | 14.86 |
Q4 2015 | 90.00 | 1.83 | 1.68 | 15.48 |
Q1 2016 | 90.00 | 1.95 | 1.97 | 16.15 |
Q2 2016 | 90.00 | 2.15 | 2.21 | 15.76 |
Q3 2016 | 90.00 | 2.53 | 2.48 | 16.26 |
Q4 2016 | 90.00 | 2.50 | 2.52 | 16.85 |
Q1 2017 | 90.00 | 2.80 | 2.79 | 17.78 |
Q2 2017 | 90.00 | 2.97 | 2.93 | 17.24 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2007 | - | - | - | - |
2008 | - | - | - | - |
2009 | 90.00 | 0.73 | 0.77 | 3.34 |
2010 | 90.00 | 1.05 | 1.05 | 3.94 |
2011 | 90.00 | 1.26 | 1.30 | 5.21 |
2012 | 90.00 | 1.48 | 1.48 | 12.40 |
2013 | 90.00 | 1.52 | 1.52 | 13.22 |
2014 | 90.00 | 1.63 | 1.63 | 14.15 |
2015 | 90.00 | 1.83 | 1.68 | 15.48 |
2016 | 90.00 | 2.50 | 2.52 | 16.85 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | - | - | - |
Q4 2009 | - | - | - |
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | 25.26 | 25.26 | 3.02 |
Q1 2013 | 23.15 | 23.15 | 2.70 |
Q2 2013 | 26.26 | 26.26 | 2.85 |
Q3 2013 | 26.93 | 26.93 | 2.82 |
Q4 2013 | 26.15 | 26.15 | 3.00 |
Q1 2014 | 33.02 | 33.02 | 3.69 |
Q2 2014 | 33.91 | 33.91 | 4.19 |
Q3 2014 | 43.67 | 43.67 | 5.29 |
Q4 2014 | 45.25 | 45.25 | 5.23 |
Q1 2015 | 40.15 | 44.08 | 4.67 |
Q2 2015 | 45.84 | 50.27 | 5.43 |
Q3 2015 | 32.29 | 35.31 | 3.88 |
Q4 2015 | 27.26 | 29.73 | 3.23 |
Q1 2016 | 27.46 | 27.14 | 3.31 |
Q2 2016 | 28.54 | 27.81 | 3.89 |
Q3 2016 | 21.29 | 21.71 | 3.31 |
Q4 2016 | 27.05 | 26.85 | 4.01 |
Q1 2017 | 25.95 | 25.99 | 4.08 |
Q2 2017 | 26.81 | 27.16 | 4.62 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2007 | - | - | - |
2008 | - | - | - |
2009 | - | - | - |
2010 | - | - | - |
2011 | - | - | - |
2012 | 25.26 | 25.26 | 3.02 |
2013 | 26.15 | 26.15 | 3.00 |
2014 | 45.25 | 45.25 | 5.23 |
2015 | 27.26 | 29.73 | 3.23 |
2016 | 27.05 | 26.85 | 4.01 |
Q2 2017
2017
Period | Medical Services | Medicine and Pharmaceutical Products |
---|---|---|
Q1 2011 | 118.62 | 11.35 |
Q2 2011 | 132.76 | 6.58 |
Q3 2011 | 110.16 | 5.99 |
Q4 2011 | 134.16 | 7.73 |
Q1 2012 | 141.87 | 12.17 |
Q2 2012 | 148.75 | 12.57 |
Q3 2012 | 133.35 | 8.91 |
Q4 2012 | 163.03 | 16.20 |
Q1 2013 | 169.97 | 13.76 |
Q2 2013 | 168.24 | 19.56 |
Q3 2013 | 158.17 | 8.92 |
Q4 2013 | 192.80 | 18.25 |
Q1 2014 | 195.44 | 12.12 |
Q2 2014 | 201.76 | 17.69 |
Q3 2014 | 177.26 | 15.52 |
Q4 2014 | 223.36 | 16.72 |
Q1 2015 | 224.02 | 16.38 |
Q2 2015 | 228.38 | 16.85 |
Q3 2015 | 215.41 | 8.52 |
Q4 2015 | 257.40 | 18.49 |
Q1 2016 | 276.15 | 8.88 |
Q2 2016 | 277.42 | 10.93 |
Q3 2016 | 265.04 | 8.13 |
Q4 2016 | 307.51 | 8.73 |
Q1 2017 | 239.94 | 62.81 |
Q2 2017 | 229.31 | 58.90 |
Period | Medical Services | Medicine and Pharmaceutical Products |
---|---|---|
2010 | 445.44 | 27.08 |
2011 | 495.70 | 31.64 |
2012 | 587.00 | 49.85 |
2013 | 689.17 | 60.48 |
2014 | 797.83 | 62.05 |
2015 | 925.20 | 60.24 |
2016 | 1,126.12 | 36.67 |
Item | Q2 2017 (e) | Q2 2017 (a) | Change |
---|---|---|---|
Average | 65.93 | 69.99 | 6.15 % |
Item | Q2 2017 (e) | Q2 2017 (a) | Change |
---|---|---|---|
Al Rajhi Capital | 68.00 | 69.99 | 2.9 % |
Albilad Capital | 67.00 | 69.99 | 4.5 % |
AlJazira Capital | 66.50 | 69.99 | 5.2 % |
Arbah Capital | 66.00 | 69.99 | 6.0 % |
Hermes | 65.00 | 69.99 | 7.7 % |
HSBC | 65.00 | 69.99 | 7.7 % |
Sico | 64.00 | 69.99 | 9.4 % |
Current | |
Market Cap (M Riyal) | 14,886.43 |
Enterprise Value (EV) (M) | 16,806.03 |
Shares Outstanding ((M)) | 97.68 |
EPS ( Riyal) (TTM) | 4.82 |
Book Value (BV) ( Riyal) | 34.96 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 31.61 |
P/E (TTM) | 31.61 |
Price/book | 4.36 |
Return on Average Assets (%) (TTM) | 7.5 |
Return on Average Equity (%) (TTM) | 14.3 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}